PRAX - Praxis Precision Medicines, Inc. | Scanr.ai
PRAX
Praxis Precision Medicines, Inc.
Manufacturing
|
Pharmaceutical Products
|
XNAS
295.81
-19.99
-6.33%
Jul 28, 3:59 PM EDT
Enlarge chart
Fullscreen chart
O 316.96H 316.96L 290.0901C 295.81Vol 438.62K
Jul 28, 2026
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders.Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression.
